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MECHANISM OF REAPPEARANCE OF CONTACT SENSITIVITY TO DNCB IN 
DESENSITIZED GUINEA PIGS 
L. POLAK , M.D. 
Department of Experimental Medicine, F. Hoffmann- La Roche & Co . Ltd., Basel, Switzerland 
The different immunologic activities of lymph node and spleen cells as compared to 
peritoneal exudate cells were studied in temporarily desensitized, DNCB-contact-sensitive 
guinea pigs. Lymph node (and spleen) lymphocytes: (a) transfer contact sensitivity to 
syngeneic recipients when harvested at the time of unresponsiveness; (b) are only 
temporarily inactivated in tolerant recipients by the desensitizing procedure; (c) enter the 
lymph node (or spleen) compartments in a higher proportion than peritoneal exudate cells; 
(d) are not susceptible to inactivation in vitro ; and (e) are not permanently desensitized when 
released into the circulation by an intravenous injection of Bordetella pertussis vaccine. 
These results indicate that the resistance of primed lymph node cells to the desensitizing 
procedure may account for the reappearance of contact sensitivity in desensitized guinea 
pigs. 
In experimental animals, a permanent and spe-
cific nonreactivity to contact sensitizers is readily 
induced by intravenous [1,2] or oral [3] adminis-
tration of the corresponding hapten. However, the 
induction of a long-lasting specific unresponsive-
ness in already sensitized individuals, which would 
allow a causa) therapy of contact dermatitis, with 
only a few exceptions [4,5] has al most always failed 
under clinical and under experimental conditions. 
The reason for this unsatisfactory situation may be 
the existence of a subpopulation of immunocompe-
tent cells participating in cell-mediated immune 
response, which cells are, however, resistant to the 
desensitizing procedure and capable of forming 
new cells replacing the inactivated effector cells. 
The existence of two types of lymphocytes pres-
ent in different compartments and differing in 
their immunologic activity has been demonstrated 
in the experiments of Turk [6] and Blazkovec et al 
[7]. They showed that lymph node lymphocytes 
from tuberculin-hypersensitive guinea pigs are less 
active in systemic passive transfer of delayed 
hypersensitivity to normal recipients than perito-
neal exudate cells [6]. Moreover, they were unable 
to accomplish a local passive transfer [7], easily 
performed with peritoneal exudate lymphocytes . 
On the other hand , it was shown that the 
increase in the number of antigen-binding cells in 
hypersensitive animals could be demonstrated 
only with lymphocytes from the lymph node com-
partment, whereas the peritoneal exudate com-
partment contained only a basic number of anti-
gen-binding cells not different from the number 
found in nonsensitized guinea pigs [8]. Further-
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more, Oort and Turk [9], using radiolabeling of 
sensitized lymphocytes in vivo, presented evidence 
that peripheral sensitized lymphocytes in skin test 
reaction sites and in peritoneal exudates of hyper-
sensitive guinea pigs were the progeny of the 
proliferating lymph node lymphocytes, the so-
called large pyroninophilic cells. 
This existence of two subpopulations of immu-
nocompetent T cells participating in the cell-
mediated immune response, namely, dividing, 
nonlymphokine-producing and nondividing, lym-
phokine-producing lymphocytes, was further dem-
onstrated by Feldman [10], Bloom et al [11], and 
Rocklin [12] . In guinea pigs hypersensitive to 
DNP-conjugates such as DNP-lysine [13] or DNP-
guinea pig skin proteins [14], a desensitizing intra-
venous injection of the antigen or the hapten 
inactivates the peripheral (peritoneal exudate) 
compartment only, leaving the lymph node com-
partment unimpaired. 
In the present paper, further evidence for the 
existence of two subpopulations of lymphocytes is 
assembled, showing that only peritoneal exudate 
lymphocytes are susceptible to the desensitizing 
effect of the intravenously administered hapten. 
Assuming that peritoneal exudate consists mainly 
of effector cells incapable of further proliferation 
whereas the lymph nodes contain lymphocytes 
capable of division and formation of new effector 
cells, it was concluded that the desensitization of 
already sensitized animals is only temporary and 
short-lasting because of resistance of lymph node 
lymphocytes to the desensitizing procedure. 
MATERIALS AND METHODS 
Animals. Inbred strain 2 guinea pigs weighing 300 to 
350 gm (recipients) or 450 to 600 gm (donors) of either sex 
fed on pelleted diet supplemented with carrots, hay, and 
water containing vitamin C were used . The animals were 
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bred at the Institute for Biomedical Research, Fiillins-
dorf, Switzerland. 
Reagents. 
ONCB: 2,4-d ini trochlorobenzene, Merck, Darmstadt, 
German Federal Republic 
ONFB: 2,4-dinitrofluorobenzene, F . Hoffmann- La Roche 
& Co. Ltd. , Basel, Switzerland 
ONBSO,: dinitrobenzene sulfonic acid sodium salt, 
Eastman Kodak, Rochester, N. Y., U .. A. 
CFA: complete Freund's adjuvant, OfFCO Laboratories, 
Detroit, Mich., U.S.A. 
Hanks ' balanced salt solution (BSS) , GIBCO, Grand 
Island, N. Y., U.S.A. 
Paraffin oil : Orakeol 6-VR White, Penna. Ref. G Co., 
Butler, Pa. , U.S.A. 
MEM: Eagle 's medium , dried, DIFCO Laboratories, 
Detroit, Mich., U.S.A. 
Medium 199 with 25 mM Hepes buffer (N-2-hydroxy-
ethylpiperazine-N'-2-ethanesulfonic acid) , glutamine, 
Earle 's salts, and NaHCO,: GrBCO. Grand Island . 
. Y., U.S.A. 
['H Jthymidine: TRK 120, aqueous solution, sp act 15.2 
Ci/mmole: Radiochemical Centre, Amersham, England 
Bordetella pertussis vaccine kindly supplied by Prof. 
St. J. Morse, The Rockefeller Institute, New York, . Y., 
U.S .A. Fetal bovine serum (FBS), FLOW Laboratories, 
England 
Sensitization and testing. Animals were sensitized 
either by epicutaneous application of 0.01 ml of a 50% 
solution of ONCB in acetone to the shaved skin of the 
guinea pigs' necks or by injecting 500 ILg of ONFB in 0.5 
ml CFA divided in 5 doses into the foot pads and napes of 
the necks. All animals were challenged 14 days after the 
sensitizing procedure by applying 0 .025 ml of 0.09 '< . 
0.05 %. and 0.03% sol utions of 0 CB in acetone to 3 skin 
areas of 2 cm' each on the clipped skin of the flank. The 
reactions were read after 24 hr and evaluated as follows: 
O. no reaction ; 0.5. some red spots; 1. confluent redness; 
2. confluent redness and swelling. The degree of contact 
sensitivity was expressed as a total of all three reactions 
in each animal. The arithmetic mean of sensitivity 
degrees of all animals in a group was considered as the 
hypersensitivity level of thi group. 
Induction of tolerance and desensit ization. To induce 
tolerance, guinea pigs were injected intravenously with 
500 mg/ kg ONBSO, in 3 ml/kg of distilled water twice 
with an interval of 2 weeks. For desensitization, 1 intra-
venous injection of 600 mg/kg ONBSO, in 4 ml/kg of di -
tilled water or 2 injections of 500 mg/kg ONBSO, in 3 
mg/ kg separated by a 3-day interval were used. 
Harvesting of lymphoid cells . Animals were killed by 
an overdose of Nembutal (Abbot AG . Zug, Switzerland!. 
Peritoneal exudate cells were obtained by washing out 
the peritoneal cavity with 150 ml of Hanks' BSS 4 days 
after an intraperitoneal injection of 30 ml of paraffin oil. 
Lymph node lymphocytes were obtained from axillary, 
femoral , subclavian. inguinal. and popliteal lymph nodes 
by teasing the cells from the nodes with forceps and 
filtering them through nylon stocking mesh into 50- ml 
plastic centrifuge tubes containing Eagle's medium . All 
the cells were washed 3 times in the corresponding media 
before use. 
For adoptive sensitization, cell suspensions from ani-
mals highly sensitive to ONCB (degree of contact ensi-
tivity > 2.5) were slowly injected intravenously into 
veins of the recipients' legs. Each animal received either 
1.5 x 10· peritoneal exudate cells or 5 x 10· viable lymph 
node or spleen cells. 
Cells from desensitized donors were harvested at the 
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time of complete unresponsiveness (mean degree of 
hypersensitivity < 0.2). i.e., 24 hr after desensitizing 
procedure . 
Labeling of ly mphoid cells in vivo . Guinea pigs sensi-
tized 3 days previously with ONFB in CFA were injected 
daily for 10 days with 0.1 mCi ['H [thymidine in 0.5 ml of 
saline intravenously. Cells were harvested as described 
above and injected intravenously into normal syngeneic 
recipients . Each animal received either 3 to 5 x 10· 
peritoneal exudate cells or 7 to 10 x 10' lymph node or 
spleen cells. 
Estimation of labeled cells. Peritoneal exudate. lymph 
node, and spleen cells were harvested as described above. 
uspensions containing 5 x 10' cells were transferred into 
glass centrifuge tubes , spun down at 200 g, the superna-
tant was discarded, and the cell pellet dissolved in I ml of 
Soluen 350 (Packard ). The solution was decolorized by 
adding 0.2 ml of isopropanol and 0.2 ml of H ,O, (30-35 '7c ) 
and was kept for 30 min at + 40°C. After addition of 15 ml 
of Oimilume (Packard) and transfer into counting vial , 
the samples were counted in a Packard scintillation 
spectrometer. 
Desensitization in vit ro. Suspensions of peritoneal 
exudate or lymph node cells (2.5 x 10' / mll from 
hypersensitive donors (degree of hypersensitivity > 2.5) 
were incubated in a 10- ' M solution of ONBSO, in 
Medium 199 + 10% FBS at 37°C for 24 hr and 2 to 4 x 10' 
peritoneal exudate or 7 to 9 x 10' lymph node cells were 
injected intravenously into tolerant recipients . 
RESULTS 
Transfer of contact sensitivity with ly mph node 
or peritoneal exudate cells from desensitized do-
nors. Contact sensitivity to dinitrochlorobenzene 
(DNCB) was readily transferred to normal synge-
neic recipients with both lymph node and perito-
neal exudate cells from hypersensitive donors. 
However. the degree of hypersensitivity achieved 
in recipients of peritoneal exudate cells was about 
50% higher than the degree achieved in recipients 
of lymph node cells despite the fact that less 
peritoneal exudate cells than lymph node cells 
were required for a successful transfer (1.5 x 108 
and 5 x 10·, respectively). Using DNCB-hypersen-
sitive guinea pigs (degree of contact sensitivity = 
2.62 ± OAI) rendered temporarily unresponsive 
(degree of contact sensitivity = 0.12 ± 0.15) by 2 
intravenous injections of 500 mg/kg dinitrobenzene 
sulfonic acid (DNBSO s) 4 days and 1 day before 
cells were harvested (desensitizing procedure), it 
was shown (Tab. n that peritoneal exudate cells 
lost the ability to transfer contact sensitivity, 
whereas the activity of lymph node cells was not 
affected by the desensitizing procedure. 
Desensitization of tolerant recipients, adoptively 
sensitized with ly mph node, spleen, or peritoneal 
exudate cells from hypersensitive donors . Com-
plete and permanent tolerance, induced in normal 
(not sensitized) guinea pigs by 2 intravenous 
injections of 500 mg/kg D BSOs separated by a 
2-week interval, was reversed by an adoptive 
transfer of peritoneal exudate, spleen, or lymph 
node cells from syngeneic hypersensitive donors. 
Again , peritoneal exudate cells were more effec-
tive, inducing a higher degree of hypersensitivity 
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with a lower number of transferred cells (Tab . II). 
A further intravenous injection of 600 mg/kg 
DNBSO s in these adoptively sensitized animals 
caused complete unresponsiveness of the recipients 
when they were challenged epicutaneously with 
D CB 24 hr later . However, after repeated chal-
lenges 7, 14, and 28 days following the desensiti z-
ing procedure (intravenous injection of D BSO,), 
it was observed that the state of unresponsiveness 
was maintained only in recipients of peritoneal 
exudate cells . In the animals adoptively sensi t ized 
with lymph node or spleen cells. the contact 
ensitivity started to reappear on day 14, reaching 
the presensitization level on day 28. This develop-
ment is comparable to the outcome of the tempo-
rary unresponsiveness induced by the desensitizing 
procedure in actively sensitized guinea pigs. 
Homing of radiolabeled ly mph node, spleen , or 
peritoneal exudate cells in syngeneic recipients. T o 
find out whether lymph node or spleen cells are 
resistant to the desensitiz ing procedure because 
they seek the corresponding compartments during 
the post-transfer period. t ransfe r experiments with 
labeled cells were performed . Lymphoid cells from 
hypersensitive donors were radiolabeled in vivo by 
10 intravenous injections of [3H lthymidine starting 
on day 3 after the epicutaneous sensitization with 
DN CB and were harvested on day 3 after the last 
Vol. 66, No. I 
injection. By autoradiography it was shown that 
about 20% of lymphoid cells were labeled by this 
method . Groups of 8 to 10 recipients were injected 
intravenously with either 3 x 108 peritoneal exu-
date or 7 x 108 lymph node or spleen cells. 
Lymph node, spleen. and peritoneal exudate 
cells of the recipients were harvested 14 days after 
transfer and the radioactivity of 5 x 107 cell was 
assessed in a scintillation spectrometer. The re-
sults given in Table III indicate that in recipients 
of labeled lymph node or spleen cells, a signifi -
cantly higher radioactivity is present in the spleen 
and in the lymph node compartments than is 
present in these compartments in recipients of 
labeled peri toneal exudate cells . These result s 
point to the possibility that, after transfer, at least 
a proportion of lymph node and spleen cells home 
to the corresponding compartments and are there-
fore protected agai nst the desensiti zing procedure . 
In vitro de ensitization of sensitized peritoneal 
exudate or lymph node ly mphocytes. In order to 
find out whether the resista nce of lymph node 
lymphocytes, a opposed to peritoneal exudate 
celis, to the desens itizing procedure is due to their 
fun ctional differences or to the differences in 
homing, peri toneal exudate or lymph node cells 
from sensi t ized donors (degree of contact sensitiv-
ity = 2.76 ± 0.32) were incubated in vitro wi th a 
TABLE I. T ransfer of contact sensitivity with lymphoid cells from desensitized donors 
Cell source 
Peritoneal exudate 


















2.27 ± 0.41 } 
0.29 z 0.35 P < 0.001 
1.01 ± 0.64 } 
0 .98 ± 0.32 P > 0 .8 
TABLE II. Desensitization of tolerant recipients adoptive/.Y sensitized u'ith primed cell~ from different compartments 
Statist ical analyses compared 14-day and 28-day results with t hose before desensitization . n. s. = not statist ica lly 















2.17 ± 0.24 
Oo/c 
1 ± 0.50 
1.1 ± 0.53 
2.27 ± 0.77 
l00 O/C 
Degree of contact sensitivity ", SD 





0.06 ± 0 .14 
3 o/c 




0. 11 ± 0.22 
10 0/, 
1.05 ± 0.59 
46 "1r 
14 
0.21 ± 0.22 
10 O/C 
P < 0.001 
0.6 ± 0.65 
60 <1'0 
n. s. 
0.8:3 ± 0.88 
75 0/, 
n.S. 




0.58 ± 0.14 
27 t"f 
p < 0.001 
1.1 ± 0.42 
11O't 
n .s. 
1.22 ± 0.37 
111 't 
n .s. 
1.80 ± 0 .56 
79 o/r 
n .s . 
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TABLE m. Distribution of lymphoid cells from different compartments of hypersensitive donors in normal recipients 
Peritoneal Spleen Lymph node exudate 
Recipients of lymph node cells 68 ± 50 112 ± 48 222 ± 130 p< om Recipients of peritoneal exu- 56 ± 42 30 ± 13 ~ 20 ± 14 date cells P < 0.01 Recipients of spleen cells 31 ± 25 312 ± 107 89 ± 49 
TABLE IV. In vitro desensitization of peritoneal exudate or ly mph node lymphocytes from hypersensitive donors 
5 x 108 cells were incubated in 30 ml Medium 199 + 10% fetal calf serum with or without 10 - ' M dinitrobenzene 
sulfonic acid. Recipients were injected with either 3 x 108 peritoneal exudate or 7 x 108 lymph node cells and 
challenged epicutaneously with DNCB 14 days later. 
Source Incubation 
of cells with 
Peritoneal exudate DNBSO, 
Peritoneal exudate 
Lymph node DNBSO, 
Lymph node 
10- 3 M concentration of the tolerogenic D BSO •. 
which does not alter the viability of lymphocytes 
(trypan blue exclusion test) in culture. The re-
maining activity after this incubation was assessed 
by adoptive transfer to tolerant recipients. Recipi-
ents of " desensitized" peritoneal exudate cells 
showed no reaction to an epicutaneous challenge 
with DNCB 14 days later, whereas recipients of 
"desensitized" lymph node cells reacted positively 
in the same manner as recipients of sensitized 
lymph node cells (Tab. IV) not submitted to the in 
vitro incubation with DNBS0 3 . 
Effect of leukocy tosis on the course of desensiti-
zation. B . pertussis vaccine induced a marked 
leukocytosis in guinea pigs on day 4 after an 
intravenous injection. Mobilization of lymphocytes 
from the lymph nodes and other depots accounts 
for this phenomenon [15]. However, the unrespon-
siveness induced by an intravenous injection of 600 
mg/kg D BSO. into sensitized guinea pigs pre-
treated with B. pertussis vaccine was only short-
lasting and not different from the desensitization 
of sensitized controls, as demonstrated in Table V. 
It seems, therefore, that lymph node lymphocytes 
remained resistant to the inactivating effect of the 
intravenously injected tolerogen (DNBSO.) even 
when they are forced to leave their compartments. 
DISCUSSION 
The induction of contact sensitivity i character-
ized by three phases: Firstly, the hapten pene-
trates into the skin where it becomes conjugated to 
proteins to form the antigen (preparatory phase ). 
Secondly, this antigen is bound by specific immu-
nocompetent cells circulating in the Iym phatic 
vessels, which are probably "switched on" in the 
periphery by this contact (antigen recognition 
phase) . Thirdly, triggered lymphocytes reach the 
paracortical area of the draining lymph nodes 
where they proliferate and differentiate into mem -
No. of Degree of 
recipients sensitivity 
± SD 
10 0.65 z 0.41} P < 0.001 10 1.75 ± 0.35 
7 
4 
0.96 ± 0.57} 
0.88 ± 0.75 P > 0.5 
ory and effector cells (proliferative phase ). The 
former form the recirculating pool and home 
mainly to the lymph node and perhaps spleen 
compartment. The latter, formed from the divid-
ing lymphocytes [9], are expelled on day 5 after 
sensitization into the blood circulation and target 
organs. 
In the secondary or "elicitation" response (mani-
festation of contact sensitivity). these effector cells 
react upon a new contact with the antigen with a 
release of Iymphokines-mediators of delayed hy-
persensitivity reactions-which induce the inflam-
matory reaction of the skin. At the same time 
specific memory cells (recirculating pool) may be 
triggered by the antigen. They enter the lymph 
nodes and spleen compartments where they again 
proliferate, differentiate, and form new popula-
tions of both effector and memory cells (booster 
effect ) . 
Since. in desensitized animals. i.e., in contact-
sensitive guinea pigs injected with a high dose of 
tolerogen, the inflammatory skin reactions upon an 
epicutaneous challenge with the hapten fail to 
appear but the activity in the lymph node com-
partment is maintained, it must be accepted that 
the function of effector cells is impaired by the 
desensitizing procedure. This impairment is fur-
ther demonstrated by the failure to transfer con-
tact sensitivity with peritoneal exudate cells from 
desensitized syngeneic donors . However, this unre-
sponsiveness appears to be only short-lasting, since 
an inflammatory skin reaction is fully elicited in 
desensitized animals 14 days after desensitization 
[16] . Whether the reappearance of the secondary 
immune response is due to recovery of the inacti-
vated effector cells or to resistance of precursor 
cells to the desensitizing procedure remains to be 
determined. Permanently tolerant guinea pigs, 
unable to become actively sensitized to the specific 
antigen [1,2], respond to an epicutaneous chal-
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TABLE V. Effect of leukocyto is on the cour e of desensitization of contact sensitized guinea pigs 
Animals sensitized to D CB were injected with 1 ml B. pertussis vaccine intravenously. On day 4 white blood cells 
were counted and then the guinea pigs desensitized with 600 mgikg D BSO. intravenously . Sensitized animals not 
treated with B . pertussis vaccine served as controls. All guinea pigs were epicutaneously challenged with D CB 7 days 
before and 1 and 28 days after desensitizing procedure. 
No. of White blood Treatment cell count 
animals ± SD 
12 
B. pertussis 34,750 ± 10,060 1 ml i.v. 
16 No treatment 6,880 ± 1,230 
lenge with the antigen when adoptively sensitized 
with primed lymphocytes from hypersensitive syn-
geneic donors [17]. Using such tolerant animals as 
recipients of primed peritoneal exudate cells, it 
was shown that the inactivation of these effector 
cells in the recipients by the desensitizing proce-
dure is long-lasting, since the unresponsiveness 
was present long after the desensitization of ac-
tively sensitized animals was reversed . 
Since sensitized peritoneal exudate cells main-
tain their activity in tolerant recipients for over one 
year (unpublished results), the prolongation of the 
unresponsiveness in desensitized recipients by 
spontaneous dying out of the transferred cells may 
be excluded. It remains to be explained why 
unresponsiveness in desensitized guinea pigs is 
only short-lasting despite the permanent inactiva-
tion of the effector cells. In guinea pigs sensitized 
with a dinitrophenylprotein conjugate (tuberculin 
type delayed hypersensitivity), the activity of the 
lymph node, as opposed to the peritoneal exudate 
compartment, was not impaired by the desensitiz-
ing procedure [13,14]. Moreover, the increased 
antigen-binding capacity of lymph node lympho-
cytes observed in sensitized guinea pigs [8] is 
maintained in desensitized animals at the time of 
unresponsiveness . The successful transfer of con-
tact sensitivity with lymph node lymphocytes 
harvested at the time of the complete skin unre-
sponsiveness from desensitized syngeneic donors is 
further evidence that the cells in the lymph node 
compartment are not inactivated by the desensi -
tizing procedure. Furthermore, the temporary de-
sensitization of tolerant recipients of lymph node 
cells, as opposed to the long-lasting desensitization 
in recipients of peritoneal exudate cells , is in 
agreement with this concept. 
Since effector cells are formed in the lymph node 
from their precursors (immunoblasts) and then 
released into the circulation [181, one may assume 
that the same process is going on even after a 
desensitizing procedure and is responsible for the 
renewal of effector cells and reappearance of con-
tact sensitivity. Either their localization predomi-
nantly in the lymph node and spleen or their 
difference in metabolism (the cells are dividing but 
not lymphokine-producing) may account for the 
relative resistance of the primed lymph node or 
Degree of contact sensitivity ± SO 
On day after desensitizing procedure 
Before 
28 
2.0 ± 0.41 0 1.54 ± 0.62 
2.27 ± 0.77 0.06 ± 0.14 1.80 ± 0.56 
spleen lymphocytes to the desensitizing procedure. 
The fact that lymph node or spleen lymphocytes 
seek the corresponding compartments (Tab. Ill) 
cannot answer definitely the question on the mech-
anisms of the temporary desensitization because 
the protection in the compartments may still be 
caused by functional differences. However, lymph 
node lymphocytes are not susceptible to in vitro 
inactivation by the tolerogen , whereas peritoneal 
exudate cells lose the capability of transferring 
contact sensitivity to normal syngeneic recipients 
following exposure to the tolerogen. Therefore, one 
may assume that the survival of the immunologic 
activity of lymph node (and spleen) cells is not 
dependent on their localization in the correspond-
ing compartment. Moreover, when these cells are 
mobilized from their compartment by treatment 
with B. pertussis vaccine and so exposed to the 
effect of the intravenously injected tolerogen , the 
duration of unresponsiveness is still not prolonged . 
This means that the cells capable of restoring 
contact sensitivity after desensitization survive the 
desensitizing procedure even if they are not shel-
tered in the lymph node or spleen compartments. 
It is known that lymphokine-producing cells are 
also present in the lymph nodes , while cells capa-
ble of proliferation and differentiation are found in 
the peritoneal exudate. However, as has already 
been mentioned, the proliferation and differentia -
tion of antigen-stimulated cells takes place mainly 
in the lymph node and spleen compartment, and 
Iymphokines are produced predominantly in the 
periphery, e.g. , in the skin. 
Therefore, the conclusion may be drawn from 
the present results that, by the desensitizing pro-
cedure, the Iymphokine-producing effector cells 
are permanently inactivated by the intravenous in-
jection of the tolerogen, and that in a relatively 
short time the new population of effector cells is 
formed from their precursors which home mainly in 
the lymph node and spleen compartments and 
which are not susceptible to the effect of the tol-
erogen. The present paper does not answer the 
question of the mechanism of this inactivation of 
the effector cells. However, in light of previous ex-
periments an inhibition by suppressor cells seems 
to be very unlikely [19]. 
An explanation of the mechanism of desensitiza-
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tion in mice was offered by Phanuphak et al [20], 
but since contact sensitivity in this species is 
different from t hat in guinea pigs [21], this expla-
nation has yet to be proved valid. To achieve 
permanent desensitization under experimental as 
well as clinical conditions, a method must be found 
for reaching a permanent inactivation of the pre-
cursor cells in the lymph node and spleen compart-
ments. This would make possible permanent reso-
lution of contact dermatitis. 
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